#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=This invention relates to implantable monitors and stimulators generally and more particularly to implantable heart monitors and heart stimulators, such as implantable cardioverter/defibrillators (ICDs).
1-1	0-4	This	_	_	
1-2	5-14	invention	_	_	
1-3	15-22	relates	_	_	
1-4	23-25	to	_	_	
1-5	26-37	implantable	_	_	
1-6	38-46	monitors	_	_	
1-7	47-50	and	_	_	
1-8	51-62	stimulators	_	_	
1-9	63-72	generally	_	_	
1-10	73-76	and	_	_	
1-11	77-81	more	_	_	
1-12	82-94	particularly	_	_	
1-13	95-97	to	_	_	
1-14	98-109	implantable	_	_	
1-15	110-115	heart	_	_	
1-16	116-124	monitors	_	_	
1-17	125-128	and	_	_	
1-18	129-134	heart	_	_	
1-19	135-146	stimulators	_	_	
1-20	146-147	,	_	_	
1-21	148-152	such	_	_	
1-22	153-155	as	_	_	
1-23	156-167	implantable	_	_	
1-24	168-180	cardioverter	_	_	
1-25	180-181	/	_	_	
1-26	181-195	defibrillators	_	_	
1-27	196-197	(	_	_	
1-28	197-201	ICDs	_	_	
1-29	201-202	)	_	_	
1-30	202-203	.	_	_	

#Text=One of the problems addressed in the design of implantable ICDs is the avoidance of unnecessary electrical shocks delivered to a patient's heart in response to rapid heart rates caused by exercise (sinus tachycardia) or by atrial fibrillation.
2-1	204-207	One	_	_	
2-2	208-210	of	_	_	
2-3	211-214	the	_	_	
2-4	215-223	problems	_	_	
2-5	224-233	addressed	_	_	
2-6	234-236	in	_	_	
2-7	237-240	the	_	_	
2-8	241-247	design	_	_	
2-9	248-250	of	_	_	
2-10	251-262	implantable	_	_	
2-11	263-267	ICDs	_	_	
2-12	268-270	is	_	_	
2-13	271-274	the	_	_	
2-14	275-284	avoidance	_	_	
2-15	285-287	of	_	_	
2-16	288-299	unnecessary	_	_	
2-17	300-310	electrical	_	_	
2-18	311-317	shocks	_	_	
2-19	318-327	delivered	_	_	
2-20	328-330	to	_	_	
2-21	331-332	a	_	_	
2-22	333-342	patient's	_	_	
2-23	343-348	heart	_	_	
2-24	349-351	in	_	_	
2-25	352-360	response	_	_	
2-26	361-363	to	_	_	
2-27	364-369	rapid	_	_	
2-28	370-375	heart	_	_	
2-29	376-381	rates	_	_	
2-30	382-388	caused	_	_	
2-31	389-391	by	_	_	
2-32	392-400	exercise	_	_	
2-33	401-402	(	_	_	
2-34	402-407	sinus	_	_	
2-35	408-419	tachycardia	_	_	
2-36	419-420	)	_	_	
2-37	421-423	or	_	_	
2-38	424-426	by	_	_	
2-39	427-433	atrial	_	_	
2-40	434-446	fibrillation	_	_	
2-41	446-447	.	_	_	

#Text=Such rhythms are known collectively as supraventricular tachycardias (SVTs).
3-1	448-452	Such	_	_	
3-2	453-460	rhythms	_	_	
3-3	461-464	are	_	_	
3-4	465-470	known	_	_	
3-5	471-483	collectively	_	_	
3-6	484-486	as	_	_	
3-7	487-503	supraventricular	_	_	
3-8	504-516	tachycardias	_	_	
3-9	517-518	(	_	_	
3-10	518-522	SVTs	_	_	
3-11	522-523	)	_	_	
3-12	523-524	.	_	_	

#Text=Studies have shown that SVTs may occur in up to 30% of ICD patients.
4-1	525-532	Studies	_	_	
4-2	533-537	have	_	_	
4-3	538-543	shown	_	_	
4-4	544-548	that	_	_	
4-5	549-553	SVTs	_	_	
4-6	554-557	may	_	_	
4-7	558-563	occur	_	_	
4-8	564-566	in	_	_	
4-9	567-569	up	_	_	
4-10	570-572	to	_	_	
4-11	573-576	30%	_	_	
4-12	577-579	of	_	_	
4-13	580-583	ICD	_	_	
4-14	584-592	patients	_	_	
4-15	592-593	.	_	_	

#Text=In theory, the shape of the QRS complex in the EGM signal during SVT will not change significantly in most patients, because ventricular depolarizations are caused by normal HIS-Purkinje conduction from the atrium to the ventricle.
5-1	594-596	In	_	_	
5-2	597-603	theory	_	_	
5-3	603-604	,	_	_	
5-4	605-608	the	_	_	
5-5	609-614	shape	_	_	
5-6	615-617	of	_	_	
5-7	618-621	the	_	_	
5-8	622-625	QRS	_	_	
5-9	626-633	complex	_	_	
5-10	634-636	in	_	_	
5-11	637-640	the	_	_	
5-12	641-644	EGM	_	_	
5-13	645-651	signal	_	_	
5-14	652-658	during	_	_	
5-15	659-662	SVT	_	_	
5-16	663-667	will	_	_	
5-17	668-671	not	_	_	
5-18	672-678	change	_	_	
5-19	679-692	significantly	_	_	
5-20	693-695	in	_	_	
5-21	696-700	most	_	_	
5-22	701-709	patients	_	_	
5-23	709-710	,	_	_	
5-24	711-718	because	_	_	
5-25	719-730	ventricular	_	_	
5-26	731-746	depolarizations	_	_	
5-27	747-750	are	_	_	
5-28	751-757	caused	_	_	
5-29	758-760	by	_	_	
5-30	761-767	normal	_	_	
5-31	768-780	HIS-Purkinje	_	_	
5-32	781-791	conduction	_	_	
5-33	792-796	from	_	_	
5-34	797-800	the	_	_	
5-35	801-807	atrium	_	_	
5-36	808-810	to	_	_	
5-37	811-814	the	_	_	
5-38	815-824	ventricle	_	_	
5-39	824-825	.	_	_	

#Text=If high ventricular rates are due to a ventricular tachycardia (VT), one can expect a very different morphology of the electrogram (EGM) signal of the ventricular depolarization (QRS complex) because of a different pattern of electrical activity of the heart during VT.
6-1	826-828	If	_	_	
6-2	829-833	high	_	_	
6-3	834-845	ventricular	_	_	
6-4	846-851	rates	_	_	
6-5	852-855	are	_	_	
6-6	856-859	due	_	_	
6-7	860-862	to	_	_	
6-8	863-864	a	_	_	
6-9	865-876	ventricular	_	_	
6-10	877-888	tachycardia	_	_	
6-11	889-890	(	_	_	
6-12	890-892	VT	_	_	
6-13	892-893	)	_	_	
6-14	893-894	,	_	_	
6-15	895-898	one	_	_	
6-16	899-902	can	_	_	
6-17	903-909	expect	_	_	
6-18	910-911	a	_	_	
6-19	912-916	very	_	_	
6-20	917-926	different	_	_	
6-21	927-937	morphology	_	_	
6-22	938-940	of	_	_	
6-23	941-944	the	_	_	
6-24	945-956	electrogram	_	_	
6-25	957-958	(	_	_	
6-26	958-961	EGM	_	_	
6-27	961-962	)	_	_	
6-28	963-969	signal	_	_	
6-29	970-972	of	_	_	
6-30	973-976	the	_	_	
6-31	977-988	ventricular	_	_	
6-32	989-1003	depolarization	_	_	
6-33	1004-1005	(	_	_	
6-34	1005-1008	QRS	_	_	
6-35	1009-1016	complex	_	_	
6-36	1016-1017	)	_	_	
6-37	1018-1025	because	_	_	
6-38	1026-1028	of	_	_	
6-39	1029-1030	a	_	_	
6-40	1031-1040	different	_	_	
6-41	1041-1048	pattern	_	_	
6-42	1049-1051	of	_	_	
6-43	1052-1062	electrical	_	_	
6-44	1063-1071	activity	_	_	
6-45	1072-1074	of	_	_	
6-46	1075-1078	the	_	_	
6-47	1079-1084	heart	_	_	
6-48	1085-1091	during	_	_	
6-49	1092-1094	VT	_	_	
6-50	1094-1095	.	_	_	

#Text=The question thus arises of how to distinguish normal QRS complexes present during SVTs from those indicative of a VT.
7-1	1096-1099	The	*[1]	8-4[2_1]	
7-2	1100-1108	question	*[1]	_	
7-3	1109-1113	thus	*[1]	_	
7-4	1114-1120	arises	*[1]	_	
7-5	1121-1123	of	*[1]	_	
7-6	1124-1127	how	*[1]	_	
7-7	1128-1130	to	*[1]	_	
7-8	1131-1142	distinguish	*[1]	_	
7-9	1143-1149	normal	*[1]	_	
7-10	1150-1153	QRS	*[1]	_	
7-11	1154-1163	complexes	*[1]	_	
7-12	1164-1171	present	*[1]	_	
7-13	1172-1178	during	*[1]	_	
7-14	1179-1183	SVTs	*[1]	_	
7-15	1184-1188	from	*[1]	_	
7-16	1189-1194	those	*[1]	_	
7-17	1195-1205	indicative	*[1]	_	
7-18	1206-1208	of	*[1]	_	
7-19	1209-1210	a	*[1]	_	
7-20	1211-1213	VT	*[1]	_	
7-21	1213-1214	.	*[1]	_	

#Text=One approach to this problem is to study the morphology of the QRS complex and discriminate normal heart beats from abnormal ones based on the similarity of the signal to a sample waveform recorded from the normal heartbeat.
8-1	1215-1218	One	_	_	
8-2	1219-1227	approach	_	_	
8-3	1228-1230	to	_	_	
8-4	1231-1235	this	*[2]	_	
8-5	1236-1243	problem	*[2]	_	
8-6	1244-1246	is	_	_	
8-7	1247-1249	to	_	_	
8-8	1250-1255	study	_	_	
8-9	1256-1259	the	_	_	
8-10	1260-1270	morphology	_	_	
8-11	1271-1273	of	_	_	
8-12	1274-1277	the	_	_	
8-13	1278-1281	QRS	_	_	
8-14	1282-1289	complex	_	_	
8-15	1290-1293	and	_	_	
8-16	1294-1306	discriminate	_	_	
8-17	1307-1313	normal	_	_	
8-18	1314-1319	heart	_	_	
8-19	1320-1325	beats	_	_	
8-20	1326-1330	from	_	_	
8-21	1331-1339	abnormal	_	_	
8-22	1340-1344	ones	_	_	
8-23	1345-1350	based	_	_	
8-24	1351-1353	on	_	_	
8-25	1354-1357	the	_	_	
8-26	1358-1368	similarity	_	_	
8-27	1369-1371	of	_	_	
8-28	1372-1375	the	_	_	
8-29	1376-1382	signal	_	_	
8-30	1383-1385	to	_	_	
8-31	1386-1387	a	_	_	
8-32	1388-1394	sample	_	_	
8-33	1395-1403	waveform	_	_	
8-34	1404-1412	recorded	_	_	
8-35	1413-1417	from	_	_	
8-36	1418-1421	the	_	_	
8-37	1422-1428	normal	_	_	
8-38	1429-1438	heartbeat	_	_	
8-39	1438-1439	.	_	_	

#Text=The sample waveform is typically referred to as a template.
9-1	1440-1443	The	_	_	
9-2	1444-1450	sample	_	_	
9-3	1451-1459	waveform	_	_	
9-4	1460-1462	is	_	_	
9-5	1463-1472	typically	_	_	
9-6	1473-1481	referred	_	_	
9-7	1482-1484	to	_	_	
9-8	1485-1487	as	_	_	
9-9	1488-1489	a	_	_	
9-10	1490-1498	template	_	_	
9-11	1498-1499	.	_	_	

#Text=One of the existing methods to discriminate between VT and normal EGM waveforms is based on the properly measured width of the QRS complex.
10-1	1500-1503	One	_	_	
10-2	1504-1506	of	_	_	
10-3	1507-1510	the	_	_	
10-4	1511-1519	existing	_	_	
10-5	1520-1527	methods	_	_	
10-6	1528-1530	to	_	_	
10-7	1531-1543	discriminate	_	_	
10-8	1544-1551	between	_	_	
10-9	1552-1554	VT	_	_	
10-10	1555-1558	and	_	_	
10-11	1559-1565	normal	_	_	
10-12	1566-1569	EGM	_	_	
10-13	1570-1579	waveforms	_	_	
10-14	1580-1582	is	_	_	
10-15	1583-1588	based	_	_	
10-16	1589-1591	on	_	_	
10-17	1592-1595	the	_	_	
10-18	1596-1604	properly	_	_	
10-19	1605-1613	measured	_	_	
10-20	1614-1619	width	_	_	
10-21	1620-1622	of	_	_	
10-22	1623-1626	the	_	_	
10-23	1627-1630	QRS	_	_	
10-24	1631-1638	complex	_	_	
10-25	1638-1639	.	_	_	

#Text=A normal QRS complex is generally narrower than the QRS complex during VT.
11-1	1640-1641	A	_	_	
11-2	1642-1648	normal	_	_	
11-3	1649-1652	QRS	_	_	
11-4	1653-1660	complex	_	_	
11-5	1661-1663	is	_	_	
11-6	1664-1673	generally	_	_	
11-7	1674-1682	narrower	_	_	
11-8	1683-1687	than	_	_	
11-9	1688-1691	the	_	_	
11-10	1692-1695	QRS	_	_	
11-11	1696-1703	complex	_	_	
11-12	1704-1710	during	_	_	
11-13	1711-1713	VT	_	_	
11-14	1713-1714	.	_	_	

#Text=However there are cases when an abnormal (VT) QRS complex will have a different morphology while remaining narrow.
12-1	1715-1722	However	_	_	
12-2	1723-1728	there	_	_	
12-3	1729-1732	are	_	_	
12-4	1733-1738	cases	_	_	
12-5	1739-1743	when	_	_	
12-6	1744-1746	an	_	_	
12-7	1747-1755	abnormal	_	_	
12-8	1756-1757	(	_	_	
12-9	1757-1759	VT	_	_	
12-10	1759-1760	)	_	_	
12-11	1761-1764	QRS	_	_	
12-12	1765-1772	complex	_	_	
12-13	1773-1777	will	_	_	
12-14	1778-1782	have	_	_	
12-15	1783-1784	a	_	_	
12-16	1785-1794	different	_	_	
12-17	1795-1805	morphology	_	_	
12-18	1806-1811	while	_	_	
12-19	1812-1821	remaining	_	_	
12-20	1822-1828	narrow	_	_	
12-21	1828-1829	.	_	_	

#Text=In those cases a more sensitive and selective method is needed to discriminate between different waveforms.
13-1	1830-1832	In	_	_	
13-2	1833-1838	those	_	_	
13-3	1839-1844	cases	_	_	
13-4	1845-1846	a	_	_	
13-5	1847-1851	more	_	_	
13-6	1852-1861	sensitive	_	_	
13-7	1862-1865	and	_	_	
13-8	1866-1875	selective	_	_	
13-9	1876-1882	method	_	_	
13-10	1883-1885	is	_	_	
13-11	1886-1892	needed	_	_	
13-12	1893-1895	to	_	_	
13-13	1896-1908	discriminate	_	_	
13-14	1909-1916	between	_	_	
13-15	1917-1926	different	_	_	
13-16	1927-1936	waveforms	_	_	
13-17	1936-1937	.	_	_	

#Text=The common approach for such morphology analysis is Correlation Waveform Analysis (CWA) or its less computationally costly counterpart, so-called Area of Difference Analysis (AD).
14-1	1938-1941	The	_	_	
14-2	1942-1948	common	_	_	
14-3	1949-1957	approach	_	_	
14-4	1958-1961	for	_	_	
14-5	1962-1966	such	_	_	
14-6	1967-1977	morphology	_	_	
14-7	1978-1986	analysis	_	_	
14-8	1987-1989	is	_	_	
14-9	1990-2001	Correlation	_	_	
14-10	2002-2010	Waveform	_	_	
14-11	2011-2019	Analysis	_	_	
14-12	2020-2021	(	_	_	
14-13	2021-2024	CWA	_	_	
14-14	2024-2025	)	_	_	
14-15	2026-2028	or	_	_	
14-16	2029-2032	its	_	_	
14-17	2033-2037	less	_	_	
14-18	2038-2053	computationally	_	_	
14-19	2054-2060	costly	_	_	
14-20	2061-2072	counterpart	_	_	
14-21	2072-2073	,	_	_	
14-22	2074-2083	so-called	_	_	
14-23	2084-2088	Area	_	_	
14-24	2089-2091	of	_	_	
14-25	2092-2102	Difference	_	_	
14-26	2103-2111	Analysis	_	_	
14-27	2112-2113	(	_	_	
14-28	2113-2115	AD	_	_	
14-29	2115-2116	)	_	_	
14-30	2116-2117	.	_	_	

#Text=Both require minimization of a function describing difference between two signals (sum of squared differences of wave data points for the case of CWA, and the sum of absolute values of the differences for AD).
15-1	2118-2122	Both	_	_	
15-2	2123-2130	require	_	_	
15-3	2131-2143	minimization	_	_	
15-4	2144-2146	of	_	_	
15-5	2147-2148	a	_	_	
15-6	2149-2157	function	_	_	
15-7	2158-2168	describing	_	_	
15-8	2169-2179	difference	_	_	
15-9	2180-2187	between	_	_	
15-10	2188-2191	two	_	_	
15-11	2192-2199	signals	_	_	
15-12	2200-2201	(	_	_	
15-13	2201-2204	sum	_	_	
15-14	2205-2207	of	_	_	
15-15	2208-2215	squared	_	_	
15-16	2216-2227	differences	_	_	
15-17	2228-2230	of	_	_	
15-18	2231-2235	wave	_	_	
15-19	2236-2240	data	_	_	
15-20	2241-2247	points	_	_	
15-21	2248-2251	for	_	_	
15-22	2252-2255	the	_	_	
15-23	2256-2260	case	_	_	
15-24	2261-2263	of	_	_	
15-25	2264-2267	CWA	_	_	
15-26	2267-2268	,	_	_	
15-27	2269-2272	and	_	_	
15-28	2273-2276	the	_	_	
15-29	2277-2280	sum	_	_	
15-30	2281-2283	of	_	_	
15-31	2284-2292	absolute	_	_	
15-32	2293-2299	values	_	_	
15-33	2300-2302	of	_	_	
15-34	2303-2306	the	_	_	
15-35	2307-2318	differences	_	_	
15-36	2319-2322	for	_	_	
15-37	2323-2325	AD	_	_	
15-38	2325-2326	)	_	_	
15-39	2326-2327	.	_	_	

#Text=However such computations as typically performed are more computationally costly and require more power than is generally desirable within implantable ICDs.
16-1	2328-2335	However	_	_	
16-2	2336-2340	such	_	_	
16-3	2341-2353	computations	_	_	
16-4	2354-2356	as	_	_	
16-5	2357-2366	typically	_	_	
16-6	2367-2376	performed	_	_	
16-7	2377-2380	are	_	_	
16-8	2381-2385	more	_	_	
16-9	2386-2401	computationally	_	_	
16-10	2402-2408	costly	_	_	
16-11	2409-2412	and	_	_	
16-12	2413-2420	require	_	_	
16-13	2421-2425	more	_	_	
16-14	2426-2431	power	_	_	
16-15	2432-2436	than	_	_	
16-16	2437-2439	is	_	_	
16-17	2440-2449	generally	_	_	
16-18	2450-2459	desirable	_	_	
16-19	2460-2466	within	_	_	
16-20	2467-2478	implantable	_	_	
16-21	2479-2483	ICDs	_	_	
16-22	2483-2484	.	_	_	

#Text=The present invention comprises a method and apparatus for reliable discrimination between ventricular depolarizations resulting from normal and abnormal propagation of depolarization wavefronts through the chambers of a patient' heart by means of a wavelet transform based method of analysis of depolarization waveforms.
17-1	2485-2488	The	_	_	
17-2	2489-2496	present	_	_	
17-3	2497-2506	invention	_	_	
17-4	2507-2516	comprises	_	_	
17-5	2517-2518	a	_	_	
17-6	2519-2525	method	_	_	
17-7	2526-2529	and	_	_	
17-8	2530-2539	apparatus	_	_	
17-9	2540-2543	for	_	_	
17-10	2544-2552	reliable	_	_	
17-11	2553-2567	discrimination	_	_	
17-12	2568-2575	between	_	_	
17-13	2576-2587	ventricular	_	_	
17-14	2588-2603	depolarizations	_	_	
17-15	2604-2613	resulting	_	_	
17-16	2614-2618	from	_	_	
17-17	2619-2625	normal	_	_	
17-18	2626-2629	and	_	_	
17-19	2630-2638	abnormal	_	_	
17-20	2639-2650	propagation	_	_	
17-21	2651-2653	of	_	_	
17-22	2654-2668	depolarization	_	_	
17-23	2669-2679	wavefronts	_	_	
17-24	2680-2687	through	_	_	
17-25	2688-2691	the	_	_	
17-26	2692-2700	chambers	_	_	
17-27	2701-2703	of	_	_	
17-28	2704-2705	a	_	_	
17-29	2706-2713	patient	_	_	
17-30	2713-2714	'	_	_	
17-31	2715-2720	heart	_	_	
17-32	2721-2723	by	_	_	
17-33	2724-2729	means	_	_	
17-34	2730-2732	of	_	_	
17-35	2733-2734	a	_	_	
17-36	2735-2742	wavelet	_	_	
17-37	2743-2752	transform	_	_	
17-38	2753-2758	based	_	_	
17-39	2759-2765	method	_	_	
17-40	2766-2768	of	_	_	
17-41	2769-2777	analysis	_	_	
17-42	2778-2780	of	_	_	
17-43	2781-2795	depolarization	_	_	
17-44	2796-2805	waveforms	_	_	
17-45	2805-2806	.	_	_	

#Text=The use of the wavelet transformation based morphology analysis method of the present invention significantly reduces the amount of computation necessary to perform the task.
18-1	2807-2810	The	_	_	
18-2	2811-2814	use	_	_	
18-3	2815-2817	of	_	_	
18-4	2818-2821	the	_	_	
18-5	2822-2829	wavelet	_	_	
18-6	2830-2844	transformation	_	_	
18-7	2845-2850	based	_	_	
18-8	2851-2861	morphology	_	_	
18-9	2862-2870	analysis	_	_	
18-10	2871-2877	method	_	_	
18-11	2878-2880	of	_	_	
18-12	2881-2884	the	_	_	
18-13	2885-2892	present	_	_	
18-14	2893-2902	invention	_	_	
18-15	2903-2916	significantly	_	_	
18-16	2917-2924	reduces	_	_	
18-17	2925-2928	the	_	_	
18-18	2929-2935	amount	_	_	
18-19	2936-2938	of	_	_	
18-20	2939-2950	computation	_	_	
18-21	2951-2960	necessary	_	_	
18-22	2961-2963	to	_	_	
18-23	2964-2971	perform	_	_	
18-24	2972-2975	the	_	_	
18-25	2976-2980	task	_	_	
18-26	2980-2981	.	_	_	

#Text=It also performs de-noising of the signal at no additional cost.
19-1	2982-2984	It	_	_	
19-2	2985-2989	also	_	_	
19-3	2990-2998	performs	_	_	
19-4	2999-3009	de-noising	_	_	
19-5	3010-3012	of	_	_	
19-6	3013-3016	the	_	_	
19-7	3017-3023	signal	_	_	
19-8	3024-3026	at	_	_	
19-9	3027-3029	no	_	_	
19-10	3030-3040	additional	_	_	
19-11	3041-3045	cost	_	_	
19-12	3045-3046	.	_	_	

#Text=The present invention may also be used to discriminate between other waveform types, for example, between normal and aberrantly conducted depolarizations of the atrium.
20-1	3047-3050	The	_	_	
20-2	3051-3058	present	_	_	
20-3	3059-3068	invention	_	_	
20-4	3069-3072	may	_	_	
20-5	3073-3077	also	_	_	
20-6	3078-3080	be	_	_	
20-7	3081-3085	used	_	_	
20-8	3086-3088	to	_	_	
20-9	3089-3101	discriminate	_	_	
20-10	3102-3109	between	_	_	
20-11	3110-3115	other	_	_	
20-12	3116-3124	waveform	_	_	
20-13	3125-3130	types	_	_	
20-14	3130-3131	,	_	_	
20-15	3132-3135	for	_	_	
20-16	3136-3143	example	_	_	
20-17	3143-3144	,	_	_	
20-18	3145-3152	between	_	_	
20-19	3153-3159	normal	_	_	
20-20	3160-3163	and	_	_	
20-21	3164-3174	aberrantly	_	_	
20-22	3175-3184	conducted	_	_	
20-23	3185-3200	depolarizations	_	_	
20-24	3201-3203	of	_	_	
20-25	3204-3207	the	_	_	
20-26	3208-3214	atrium	_	_	
20-27	3214-3215	.	_	_	

#Text=The specific embodiments disclosed below, however, are directed toward distinguishing normal and aberrantly conducted ventricular depolarizations.
21-1	3216-3219	The	_	_	
21-2	3220-3228	specific	_	_	
21-3	3229-3240	embodiments	_	_	
21-4	3241-3250	disclosed	_	_	
21-5	3251-3256	below	_	_	
21-6	3256-3257	,	_	_	
21-7	3258-3265	however	_	_	
21-8	3265-3266	,	_	_	
21-9	3267-3270	are	_	_	
21-10	3271-3279	directed	_	_	
21-11	3280-3286	toward	_	_	
21-12	3287-3301	distinguishing	_	_	
21-13	3302-3308	normal	_	_	
21-14	3309-3312	and	_	_	
21-15	3313-3323	aberrantly	_	_	
21-16	3324-3333	conducted	_	_	
21-17	3334-3345	ventricular	_	_	
21-18	3346-3361	depolarizations	_	_	
21-19	3361-3362	.	_	_	

#Text=Three embodiments of wavelet based morphology analysis methods according to the present invention are described in more detail below.
22-1	3363-3368	Three	_	_	
22-2	3369-3380	embodiments	_	_	
22-3	3381-3383	of	_	_	
22-4	3384-3391	wavelet	_	_	
22-5	3392-3397	based	_	_	
22-6	3398-3408	morphology	_	_	
22-7	3409-3417	analysis	_	_	
22-8	3418-3425	methods	_	_	
22-9	3426-3435	according	_	_	
22-10	3436-3438	to	_	_	
22-11	3439-3442	the	_	_	
22-12	3443-3450	present	_	_	
22-13	3451-3460	invention	_	_	
22-14	3461-3464	are	_	_	
22-15	3465-3474	described	_	_	
22-16	3475-3477	in	_	_	
22-17	3478-3482	more	_	_	
22-18	3483-3489	detail	_	_	
22-19	3490-3495	below	_	_	
22-20	3495-3496	.	_	_	

#Text=A first disclosed embodiment compares template and unknown waveforms in the wavelet domain by ordering wavelet coefficients of the template and unknown waveforms by absolute amplitude and comparing the resulting orders of the coefficients.
23-1	3497-3498	A	_	_	
23-2	3499-3504	first	_	_	
23-3	3505-3514	disclosed	_	_	
23-4	3515-3525	embodiment	_	_	
23-5	3526-3534	compares	_	_	
23-6	3535-3543	template	_	_	
23-7	3544-3547	and	_	_	
23-8	3548-3555	unknown	_	_	
23-9	3556-3565	waveforms	_	_	
23-10	3566-3568	in	_	_	
23-11	3569-3572	the	_	_	
23-12	3573-3580	wavelet	_	_	
23-13	3581-3587	domain	_	_	
23-14	3588-3590	by	_	_	
23-15	3591-3599	ordering	_	_	
23-16	3600-3607	wavelet	_	_	
23-17	3608-3620	coefficients	_	_	
23-18	3621-3623	of	_	_	
23-19	3624-3627	the	_	_	
23-20	3628-3636	template	_	_	
23-21	3637-3640	and	_	_	
23-22	3641-3648	unknown	_	_	
23-23	3649-3658	waveforms	_	_	
23-24	3659-3661	by	_	_	
23-25	3662-3670	absolute	_	_	
23-26	3671-3680	amplitude	_	_	
23-27	3681-3684	and	_	_	
23-28	3685-3694	comparing	_	_	
23-29	3695-3698	the	_	_	
23-30	3699-3708	resulting	_	_	
23-31	3709-3715	orders	_	_	
23-32	3716-3718	of	_	_	
23-33	3719-3722	the	_	_	
23-34	3723-3735	coefficients	_	_	
23-35	3735-3736	.	_	_	

#Text=The second and third disclosed embodiments perform analogs of CWA and AD computations in the wavelet domain.
24-1	3737-3740	The	_	_	
24-2	3741-3747	second	_	_	
24-3	3748-3751	and	_	_	
24-4	3752-3757	third	_	_	
24-5	3758-3767	disclosed	_	_	
24-6	3768-3779	embodiments	_	_	
24-7	3780-3787	perform	_	_	
24-8	3788-3795	analogs	_	_	
24-9	3796-3798	of	_	_	
24-10	3799-3802	CWA	_	_	
24-11	3803-3806	and	_	_	
24-12	3807-3809	AD	_	_	
24-13	3810-3822	computations	_	_	
24-14	3823-3825	in	_	_	
24-15	3826-3829	the	_	_	
24-16	3830-3837	wavelet	_	_	
24-17	3838-3844	domain	_	_	
24-18	3844-3845	.	_	_	

#Text=All three methods produce good discrimination of QRS complexes during VTs from normal QRS complexes during SVTs and may be readily implemented in the embedded environments of implantable ICDs.
25-1	3846-3849	All	_	_	
25-2	3850-3855	three	_	_	
25-3	3856-3863	methods	_	_	
25-4	3864-3871	produce	_	_	
25-5	3872-3876	good	_	_	
25-6	3877-3891	discrimination	_	_	
25-7	3892-3894	of	_	_	
25-8	3895-3898	QRS	_	_	
25-9	3899-3908	complexes	_	_	
25-10	3909-3915	during	_	_	
25-11	3916-3919	VTs	_	_	
25-12	3920-3924	from	_	_	
25-13	3925-3931	normal	_	_	
25-14	3932-3935	QRS	_	_	
25-15	3936-3945	complexes	_	_	
25-16	3946-3952	during	_	_	
25-17	3953-3957	SVTs	_	_	
25-18	3958-3961	and	_	_	
25-19	3962-3965	may	_	_	
25-20	3966-3968	be	_	_	
25-21	3969-3976	readily	_	_	
25-22	3977-3988	implemented	_	_	
25-23	3989-3991	in	_	_	
25-24	3992-3995	the	_	_	
25-25	3996-4004	embedded	_	_	
25-26	4005-4017	environments	_	_	
25-27	4018-4020	of	_	_	
25-28	4021-4032	implantable	_	_	
25-29	4033-4037	ICDs	_	_	
25-30	4037-4038	.	_	_	

#Text=It is believed the embodiments disclosed may also be usefully applied to discriminate between other waveform types, as discussed above.
26-1	4039-4041	It	_	_	
26-2	4042-4044	is	_	_	
26-3	4045-4053	believed	_	_	
26-4	4054-4057	the	_	_	
26-5	4058-4069	embodiments	_	_	
26-6	4070-4079	disclosed	_	_	
26-7	4080-4083	may	_	_	
26-8	4084-4088	also	_	_	
26-9	4089-4091	be	_	_	
26-10	4092-4100	usefully	_	_	
26-11	4101-4108	applied	_	_	
26-12	4109-4111	to	_	_	
26-13	4112-4124	discriminate	_	_	
26-14	4125-4132	between	_	_	
26-15	4133-4138	other	_	_	
26-16	4139-4147	waveform	_	_	
26-17	4148-4153	types	_	_	
26-18	4153-4154	,	_	_	
26-19	4155-4157	as	_	_	
26-20	4158-4167	discussed	_	_	
26-21	4168-4173	above	_	_	
26-22	4173-4174	.	_	_	
